Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study

Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study

BackgroundHepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) portends a worse prognosis. The objective of this study was to compare the efficacy of percutaneous radiofrequency ablation (RFA) combined with transarterial chemoembolization (TACE) plus sorafenib to that of the most...

Full description

Bibliographic Details
Main Authors: Xiaoyan Ding, Wei Sun, Jinglong Chen, Wei Li, Yanjun Shen, Xiaodi Guo, Ying Teng, Xiaomin Liu, Shasha Sun, Jianying Wei, Wendong Li, Hui Chen, Bozhi Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
type I/II portal vein tumor thrombus
percutaneous radiofrequency ablation
sorafenib
transarterial chemoembolization
hepatocellular carcinoma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.578633/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.578633/full

Similar Items